CHARACTERIZATION OF A CLASS OF PEPTIDE BORONATES WITH NEUTRAL P1 SIDE-CHAINS AS HIGHLY SELECTIVE INHIBITORS OF THROMBIN

被引:50
作者
DEADMAN, JJ
ELGENDY, S
GOODWIN, CA
GREEN, D
BABAN, JA
PATEL, G
SKORDALAKES, E
CHINO, N
CLAESON, G
KAKKAR, VV
SCULLY, MF
机构
[1] Thrombosis Research Institute, London SM2 5TF
关键词
D O I
10.1021/jm00009a012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Z-D-Phe-Pro-boroMpg-OPin (9a)(1,2) has been shown previously to be a highly specific inhibitor of thrombin in spite of lacking an arginine-like guanidino group at the P1 site.(1) A range of compounds have been synthesized based upon this lead compound, varying the neutral side chain at the P1 site. Of the 20 examples based upon the structures at P2 and P3 of Z-D-X-Pro (X being Phe or beta,beta-diphenylalanine), all were found to be effective inhibitors of thrombin (K-i's between 10 and 100 nM). Furthermore all exhibited a high specificity toward thrombin having values for st K-i(trypsin)/K-i(thrombin) ratio of between 10- and 100-fold. High ratio values were found for a number of the compounds tested against a range of serine proteinases (plasmin, factor Xa, kallikrein, urokinase, protein Ca, chymotrypsin, elastase, and cathepsin G).(2) AS far as potency toward thrombin, compounds containing the methoxypropyl group at P1 were favored over those with a methoxy grouping on a shorter alkyl chain (8) or without the methoxy group (1-5). The compounds display potent anticoagulant activity with values for 18 in thrombin time of 0.63 mu M and in activated partial thromboplastin time of 2.0 mu M. B-11 NMR has been used to confirm interaction of the boron atom with the active site. From the high specificity shown with all the compounds we propose that the compounds, constitute a new class of thrombin inhibitors.
引用
收藏
页码:1511 / 1522
页数:12
相关论文
共 61 条
  • [1] B-11 NUCLEAR MAGNETIC-RESONANCE STUDIES OF THE STRUCTURE OF THE TRANSITION-STATE ANALOG PHENYLBORONIC ACID BOUND TO CHYMOTRYPSIN
    ADEBODUN, F
    JORDAN, F
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (01) : 309 - 310
  • [2] BENZAMIDOMETHANEBORONIC ACID - SYNTHESIS AND INHIBITION OF CHYMOTRYPSIN
    AMIRI, P
    LINDQUIST, RN
    MATTESON, DS
    SADHU, KM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 234 (02) : 531 - 536
  • [3] N-15 NMR-SPECTROSCOPY OF THE CATALYTIC-TRIAD HISTIDINE OF A SERINE PROTEASE IN PEPTIDE BORONIC ACID INHIBITOR COMPLEXES
    BACHOVCHIN, WW
    WONG, WYL
    FARRJONES, S
    SHENVI, AB
    KETTNER, CA
    [J]. BIOCHEMISTRY, 1988, 27 (20) : 7689 - 7697
  • [4] ACTIVE SITE-DIRECTED SYNTHETIC THROMBIN INHIBITORS - SYNTHESIS, INVITRO AND INVIVO ACTIVITY PROFILE OF BMY 44621 AND ANALOGS - AN EXAMINATION OF THE ROLE OF THE AMINO GROUP IN THE D-PHE-PRO-ARG-H SERIES
    BALASUBRAMANIAN, N
    STLAURENT, DR
    FEDERICI, ME
    MEANWELL, NA
    WRIGHT, JJ
    SCHUMACHER, WA
    SEILER, SM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) : 300 - 303
  • [5] B-11 NMR-STUDIES OF AN ARYL BORONIC ACID BOUND TO CHYMOTRYPSIN AND SUBTILISIN
    BALDWIN, JE
    CLARIDGE, TDW
    DEROME, AE
    SCHOFIELD, CJ
    SMITH, BD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (01) : 9 - 12
  • [6] BALDWIN JE, 1991, J CHEM SOC CHEM COMM, V8, P573
  • [7] BODE W, COMMUNICATION
  • [8] STRUCTURAL-ANALYSIS OF SPECIFICITY - ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGS OF REACTION INTERMEDIATES
    BONE, R
    FRANK, D
    KETTNER, CA
    AGARD, DA
    [J]. BIOCHEMISTRY, 1989, 28 (19) : 7600 - 7609
  • [9] ARGATROBAN, A SELECTIVE, POTENT THROMBIN INHIBITOR
    BUSH, LR
    [J]. CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (03): : 247 - 263
  • [10] FIBRINOLYTIC COMPROMISE BY SIMULTANEOUS ADMINISTRATION OF SITE-DIRECTED INHIBITORS OF THROMBIN
    CALLAS, D
    BACHER, P
    IQBAL, O
    HOPPENSTEADT, D
    FAREED, J
    [J]. THROMBOSIS RESEARCH, 1994, 74 (03) : 193 - 205